Orthopaedic Devices Global Market estimated to be worth $53.6 billion by 2027
Bone is a hard biological tissue consisting of cells residing in the bone matrix and these bones are made of organic substances such as amorphous ground substances, collagen, and a mineral phase such as calcium carbonate, calcium phosphate, and hydroxyapatite crystals. Bone serves as a guardian for various vital organs by providing mechanical stability to the body and aids in locomotion. The musculoskeletons are prone to various types of injuries, fractures, diseases and deformities, which can be corrected by using orthopaedic implants. Some of the most common musculoskeletal regions are hip, knee, spine, upper extremities consisting of hand, wrist, shoulder, elbow, and lower extremities such as limb, ankle, and foot. Orthopaedic implants are defined as medical devices which aids in fixation of bones, replacement and reconstruction of articulating surfaces of joints and muscles. These orthopaedic implants are made from various types of materials such as metals, polymers, ceramic, and biologics thereby providing strength to the musculoskeletons.
The orthopaedic devices global market is expected to reach $53,607.2 million by 2027 growing at a high single digit CAGR from 2020 to 2027. Some of the factors driving the market are increase in incidence and prevalence of osteoporosis, osteoarthritis, degenerative disc disease, herniated disc, scoliosis, kyphosis, lordosis, Ankylosing spondylitis, sacroiliac joint dysfunction, and, sports injuries, trauma, or abnormal anatomical developments leading to chronic disability and increase in the aging population, technological advancement, and acquisitions. Rise in the number of product recalls, lack of skilled professionals, adverse effects of implants are restraining the growth of the market. The stringent regulatory process and alternative treatments that include medicines and high cost of the implants are some of the threats to the market.
Orthopaedic devices market is classified based on products, surgery type, end-users and geography. The products are further categorized into eight sub-segments such as knee, hip, extremities (upper and lower extremities), spine (fusion and non-fusion devices), trauma, craniomaxillofacial, sports medicine and orthobiologics (synthetics, demineralized bone matrix, machined bone allografts and others such as xenografts). Based on the surgery type, the orthopaedic devices global market is segmented into open surgery, minimally invasive, and robotic-assisted surgery. Based on end-users, the orthopaedic devices global market is segmented into hospitals, orthopaedic clinics, and ambulatory surgical centers. The orthopaedic devices global market by geography is segmented into North America, Europe, Asia-Pacific and the Rest of the world (RoW).
The promising future of orthopaedic devices is further substantiated in the report through several IQ4I analyses of the orthopaedic devices associated funding scenario, procedural volume, regional and country-wise procedure analysis, price analysis, and patent trends.
The enormous funding of ~$103.18 million raised by the various orthopaedic device companies during 2019 – 2020 to increase in product development, commercialization, and to expand the geographical reach of these highly efficient products across the various musculoskeletal repair and reconstruction. Escalating demand for value based healthcare services from the value centric patient population, the chronic disease and geriatric population dynamics, need to democratize the value based healthcare services and mitigate the deficit of healthcare workforce, changing economic conditions and increasing awareness of the patients and individuals of the importance of self care and adoption of preventative solutions are all compelling orthopaedic device companies to continuously invest in research and develop the most efficient, rapid, unbiased products. To occupy more of the patient-driven market share with value-based products, companies are strengthening their R&D capabilities so as to broaden and differentiate their product offerings with the recent technological innovations and thus gain a competitive edge over their peers.
To increase their market reach and to perpetuate their leading position in the market, orthopaedic device companies have adopted the strategies of co-developing of innovative orthopaedic implants through collaborations or partnerships, up-scaling of their orthopaedic products, launching of novel orthopaedic implants with new manufacturing material, technology, and acquisitions. The orthopaedic devices market is consolidated with the top 6 players occupying majority of the market share. Some of the major players in the Orthopaedic Devices global market include Stryker Corporation (U.S.), Medtronic Plc (Ireland), Zimmer Biomet Holdings Inc. (U.S.), Johnson & Johnson (DePuy Synthes, U.S.), Smith & Nephew Plc (U.K.), NuVasive Inc (U.S.), Globus Medical Inc. (U.S.), Arthrex Inc. (U.S.), Colfax Corporation (DJO, LLC, U.S.), and B. Braun Melsungen AG (Germany) and others.